Analysis of clinicopathological features and prognostic factors of non‑Hodgkin's intravascular large B‑cell lymphoma

Liu,Ying; Ma,Yue; Zhou,Huihui; Zhou,Xiuzhi; Shao,Juan

doi:10.3892/ol.2020.11908

Analysis of clinicopathological features and prognostic factors of non‑Hodgkin's intravascular large B‑cell lymphoma

Authors:
- Ying Liu
- Yue Ma
- Huihui Zhou
- Xiuzhi Zhou
- Juan Shao
View Affiliations

Affiliations: Department of Oncology, Pathology and Dermatology, Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, P.R. China, Department of Urology, Mianyang Central Hospital, Mianyang, Sichuan 621000, P.R. China, School of Basic Medical Sciences, Binzhou Medical University, Yantai, Shandong 264003, P.R. China
Published online on: July 24, 2020 https://doi.org/10.3892/ol.2020.11908
Article Number: 43

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Non‑Hodgkin's intravascular large B‑cell lymphoma is a highly invasive extranodal lymphoma. The proliferating tumor cells invade the small vessels and capillaries of different organs. The clinical symptoms are atypical, there is lack of specificity, and the molecular and biological behaviors are not clear, thus, the present study aimed to improve the current understanding of non‑Hodgkin's intravascular large B‑cell lymphoma (IVL) and provide an accurate basis for clinical treatment and prognosis, by retrospectively analyzing and summarizing the clinicopathological features, immunohistochemical findings and molecular characteristics of 17 patients with IVL. The Kaplan‑Meier method and log rank test were implemented to determine survival outcomes. Fisher's exact test was used to determine the association between clinicopathological features and the expression levels of Ki‑67, c‑Myc, B‑cell lymphoma 6 (Bcl‑6) and B‑cell lymphoma 2 (Bcl‑2), while multivariate Cox regression analysis was performed to identify the independent risk factors that affect the survival rates of patients with IVL. P<0.05 was considered to indicate a statistically significant difference. Among the 17 patients with IVL, 13 cases (76.47%) occurred in the adrenal gland and four cases (23.53%) occurred on the skin demonstrated positive IgH gene rearrangement. FISH analysis indicated that cleavage of the c‑Myc gene was closely associated with sex, hypertension status and tumor size, while cleavage of the Bcl‑6 gene was closely associated with tumor size parameters. Overall, the results suggest that the Ki‑67 proliferation index is an independent risk factor for the prognosis (survival time) of patients with IVL.

View Figures

View References

1	Khojeini EV and Song JY: Intravascular large B-cell lymphoma presenting as interstitial lung disease. Case Rep Pathol. 2014:9280652014.PubMed/NCBI
2	Sabattini E, Bacci F, Sagramoso C and Pileri SA: WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica. 102:83–87. 2010.PubMed/NCBI
3	Ferreri AJ, Dognini GP, Campo E, Willemze R, Seymour JF, Bairey O, Martelli M, De Renz AO, Doglioni C, Montalbán C, et al: Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions. Haematologica. 92:486–492. 2007. View Article : Google Scholar : PubMed/NCBI
4	Hope CB and Pincus LB: Primary cutaneous B-cell lymphomas with large cell predominance - primary cutaneous follicle center lymphoma, diffuse large B-cell lymphoma, leg type and intravascular large B-cell lymphoma. Semin Diagn Pathol. 34:85–98. 2017. View Article : Google Scholar : PubMed/NCBI
5	Lazzari I, Galetti C, Corvalli G, Bernardi R, Gianotti G, Sagramoso C and Calogero P: Intravascular large B-cell lymphoma as a cause of terminal acute respiratory distress syndrome: atypical presentation of a rare disease. Aging Clin Exp Res. 30:97–99. 2018. View Article : Google Scholar : PubMed/NCBI
6	Murase T, Yamaguchi M, Suzuki R, Okamoto M, Sato Y, Tamaru J, Kojima M, Miura I, Mori N, Yoshino T and Nakamura S: Intravascular large B-cell lymphoma (IVLBCL): A clinicopathologic study of 96 cases with special reference to the immnophenotypic heterogeneity of CD5. Blood. 109:478–485. 2007. View Article : Google Scholar : PubMed/NCBI
7	Shimada K, Kosugi H, Narimatsu H, Shimada S, Suzuki T, Ito M, Kinoshita T, Mori N and Naoe T: Sustainde remission after rituximab-containing chemotherapy for intravascular large B-cell lymphoma. J Clin Exp Hematol. 48:25–28. 2008. View Article : Google Scholar
8	Chen Y, Ding C, Lin Q, Yang K, Li Y and Chen S: Primary intravascular large B-cell lymphoma of the lung: A review and case report. J Thorace Dis. 6:E242–E245. 2014.
9	Liu CL, Lai N, Zhou Y, Li S, Chen R and Zhang N: Intravascular large B-cell lymphoma confirmed by lung biopsy. Int J Clin Exp Pathol. 7:6301–6306. 2014.PubMed/NCBI
10	Kohan AA, Paganini L, Biedak P, Arma JI, Dalurzo MC and Garcia-Monaco RD: Pulmonary intravascular lymphoma detected by FDG PET-CT: A case report. Rev Esp Med Nucl Imagen Mol. 32:318–320. 2013.PubMed/NCBI
11	Bhargava P, Siddiqui F, Aggarwal B, Moore BE and Elble RJ: A unique case of intravascular lymphoma mimicking encephalomyeloradiculo neuropathy. Neurologist. 20:18–21. 2015. View Article : Google Scholar : PubMed/NCBI
12	Colavolpe C, Ebbo M, Trousse D, Khibri H, Franques J, Chetaille B, Coso D, Ouvrier MJ, Gastaud L, Guedj E and Schleinitz N: FDG-PET/CT is a pivotal imaging modality to diagnose rare intravascular large B-cell lymphoma: Case report and review of literature. Hematol Oncol. 33:99–109. 2015. View Article : Google Scholar : PubMed/NCBI
13	Nixon BK, Kussick SJ, Carlon MJ and Rubin BP: Intravascular large B-cell lymphoma involving hemangiomas: An unusual presentation of a rare neoplasm. Mod Pathol. 18:1121–1126. 2005. View Article : Google Scholar : PubMed/NCBI
14	Cerroni L, Massone C, Kutzner H, Mentzel T, Umbert P and Kerl H: Intravascular large T-cell or NK-cell lymphoma: A rare variant of intravascular large cell lymphoma with frequent cytotoxic phenotype and association with Epstein-Barr virus infection. Am J Surg Pathol. 32:891–898. 2008. View Article : Google Scholar : PubMed/NCBI
15	Ardighieri L, Lonardi S, Vermi W, Medicina D, Cerroni L and Facchetti F: Intralymphatic atypical T-cell proliferation in a cutaneous hemangioma. J Cutan Pathol. 37:497–503. 2010. View Article : Google Scholar : PubMed/NCBI
16	Baum CL, Stone MS and Liu V: Atypical intravascular CD30+ T cell proliferation following trauma in a healthy 17-year-old male: First reported case of a potential diagnostic pitfall and literature review. J Cutan Pathol. 36:350–354. 2009. View Article : Google Scholar : PubMed/NCBI
17	Xie JL, Shi Y, Zhou XG, Jin Y, Zheng XD and Wei XJ: Intralymphatic accumulation of lymphocytes mimicking intravascular lymphomatosis. Zhonghua Bing Li Xue Za Zhi. 39:518–521. 2010.(In Chinese). PubMed/NCBI
18	Katayama K, Tomoda K, Ohya T, Asada H, Ohbayashi C and Kimura H: Ground-glass opacities and a solitary nodule on chest in intravascular large B-cell lymphoma. Respirol Case Rep. 3:108–111. 2015.PubMed/NCBI
19	Yu H, Chen G, Zhang RX and Jin X: Primary intravascular large B-cell lymphoma of lung: A report of one case and review. Diagn Pathol. 7:702012. View Article : Google Scholar : PubMed/NCBI
20	Maekawa T, Kornime M, Murata S, Fukushima N and Ohtsuki M: Random skin biopsy of patients with intravascular large B-cell lymphoma associated with thrombocytopenia and coagulation abnormalities: Proposal of a modified biopsy method. J Dermatol. 42:318–321. 2015. View Article : Google Scholar : PubMed/NCBI
21	Mahasneh T, Harrington Z, Williamson J, Alkhawaja D, Duflou J and Shin JS: Intravascular large B-cell lymphoma complicated by invasive pulmonary aspergillosis: A rare presentation. Respirol Case Rep. 2:67–69. 2014.PubMed/NCBI
22	Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, et al: WHO-EORTC classification for cutaneous lymphomas. Blood. 105:3768–3785. 2005. View Article : Google Scholar : PubMed/NCBI
23	Wenxue W: Progress in diagnosis and treatment of intravascular lymphomas. Modern Oncol. 14:1624–1627. 2006.
24	Chen M, Qiu B, Kong J and Chen J: Angiotropic T cell lymphoma. Chin Med J (Engl). 111:762–764. 1998.PubMed/NCBI
25	Kobayashi H, Abe Y, Miura D, Narita K, Kitadate A, Takeuchi M and Matsue K: Limited efficacy of high-dose methotrexate in patients with neurolymphomatosis. Int J Hematol. 109:286–291. 2019. View Article : Google Scholar : PubMed/NCBI
26	Donald JS, Barnthouse N and Chen DL: Rare variant of intravascular Large B-cell lymphoma with hemophagocytic syndrome. Clin Nucl Med. 43:e125–e126. 2018. View Article : Google Scholar : PubMed/NCBI
27	Ogasawara T, Ebata N, Hamasaki J, Marshall S, Kawauchi K, Ohshima K, Mori N and Sakura H: BCL2, BCL6, and MYC-positive intravascular large B-cell lymphoma presenting with bilateral adrenal gland lesions. Rinsho Ketsueki. 60:570–576. 2019.(In Japanese). PubMed/NCBI